Clinical Trial Update: Use of Bismuth Subsalicylate in Clostridium Difficile Colitis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Bismuth Subsalicylate for Clostridioides difficile infection has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Bismuth subsalicylate (bismuth subsalicylate)

Snippet

Sponsor: Bassett Healthcare | Conditions: Clostridium Difficile Infection | Phase 4 | Status: WITHDRAWN